Literature DB >> 28769115

Rheumatoid arthritis: Regulating the osteoclast workforce.

Jessica McHugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28769115     DOI： 10.1038/nrrheum.2017.129

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.

Authors:  Koichi Murata; Celestia Fang; Chikashi Terao; Eugenia G Giannopoulou; Ye Ji Lee; Min Joon Lee; Se-Hwan Mun; Seyeon Bae; Yu Qiao; Ruoxi Yuan; Moritoshi Furu; Hiromu Ito; Koichiro Ohmura; Shuichi Matsuda; Tsuneyo Mimori; Fumihiko Matsuda; Kyung-Hyun Park-Min; Lionel B Ivashkiv
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745
  1 in total
  2 in total

1.  Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways.

Authors:  Kaiqiang Sun; Fanqi Kong; Feng Lin; Fudong Li; Jingchuan Sun; Changzhen Ren; Bing Zheng; Jiangang Shi
Journal:  Mediators Inflamm       Date:  2022-06-16       Impact factor: 4.529

2.  Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.

Authors:  Jiahong Meng; Chenhe Zhou; Wenkan Zhang; Wei Wang; Bin He; Bin Hu; Guangyao Jiang; Yangxin Wang; Jianqiao Hong; Sihao Li; Jiamin He; Shigui Yan; Weiqi Yan
Journal:  J Cell Mol Med       Date:  2019-07-21       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.